Published in CNS Drugs on February 01, 2011
Clozapine: a review of clinical practice guidelines and prescribing trends. BMC Psychiatry (2014) 0.93
Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison. Schizophr Res Treatment (2014) 0.88
Development of telehealth dialogues for monitoring suicidal patients with schizophrenia: consumer feedback. Community Ment Health J (2013) 0.86
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data. Schizophr Res (2014) 0.81
Suicide prevention in schizophrenia spectrum disorders and psychosis: a systematic review. BMC Psychol (2013) 0.79
Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol (2013) 0.78
Development of a recovery manual for suicidal patients with schizophrenia: consumer feedback. Community Ment Health J (2011) 0.77
Using telehealth to augment an intensive case monitoring program in veterans with schizophrenia and suicidal ideation: A pilot trial. Psychiatry Res (2016) 0.76
Recovering from hallucinations: a qualitative study of coping with voices hearing of people with schizophrenia in Hong Kong. ScientificWorldJournal (2012) 0.75
Brain-Derived Neurotrophic Factor and Suicide in Schizophrenia: Critical Role of Neuroprotective Mechanisms as an Emerging Hypothesis. Indian J Psychol Med (2016) 0.75
Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region. Asia Pac Psychiatry (2016) 0.75
Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry (1997) 10.29
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry (2003) 3.85
Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol (1997) 3.62
Suicide within 12 months of contact with mental health services: national clinical survey. BMJ (1999) 3.61
Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. Am J Psychiatry (1996) 3.61
Hopelessness and eventual suicide: a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry (1985) 3.57
National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry (1991) 3.53
Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry (1998) 3.47
Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry (2002) 3.44
Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry (2005) 3.21
The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry (2005) 3.15
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry (2005) 2.64
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry (2003) 2.15
Impact of clozapine on completed suicide. Am J Psychiatry (2001) 1.93
Suicide and other unexpected deaths among psychiatric in-patients. The Bristol confidential inquiry. Br J Psychiatry (1991) 1.92
Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry (2003) 1.83
Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res (2005) 1.77
Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry (1997) 1.72
Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry (1995) 1.67
Treatment-resistant schizophrenia--the role of clozapine. Curr Med Res Opin (1997) 1.64
Conditions predisposing to suicide: a review. J Nerv Ment Dis (1977) 1.62
Mortality in current and former users of clozapine. Epidemiology (1997) 1.58
Hospital suicides: are there preventable factors? Profile of the psychiatric hospital suicide. Br J Psychiatry (1989) 1.55
Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatr Scand (2006) 1.55
Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups. Dan Med Bull (2007) 1.54
Clozapine diminishes suicidal behavior: a retrospective evaluation of clinical records. J Clin Psychiatry (2005) 1.52
Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull (1990) 1.52
Mental disorder in elderly suicides: a case-control study. Am J Psychiatry (2002) 1.49
A study of suicide in schizophrenic in-patients. Br J Psychiatry (1992) 1.45
Suicide and schizophrenia: a review of literature for the decade (1990-1999) and implications for mental health nursing. Issues Ment Health Nurs (2003) 1.42
The psychosocial treatment of schizophrenia: an update. Am J Psychiatry (2001) 1.41
Suicide in chronic schizophrenia. Br J Psychiatry (1982) 1.39
Treatment of schizophrenia 1999. The expert consensus guideline series. J Clin Psychiatry (1999) 1.36
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry (2004) 1.35
OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry Suppl (2002) 1.35
Suicide and schizophrenia. J Psychopharmacol (2001) 1.34
Risk factors for suicide among patients with schizophrenia. Acta Psychiatr Scand (1987) 1.34
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial. Eur Neuropsychopharmacol (1997) 1.28
Postpsychotic depression in schizophrenia. Arch Gen Psychiatry (1976) 1.25
Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res (2001) 1.13
Characterization of schizophrenic patients who commit suicide. Am J Psychiatry (1984) 1.12
"Akinetic depression" in schizophrenia. Arch Gen Psychiatry (1978) 1.10
Mental disorders in elderly suicide. Int Psychogeriatr (1995) 1.09
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophr Res (2010) 1.06
Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann Clin Psychiatry (2006) 1.06
Treatment of suicidality in schizophrenia. Ann N Y Acad Sci (2001) 1.06
Relapse prevention and recovery in the treatment of schizophrenia. J Clin Psychiatry (2006) 1.05
Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. J Clin Psychiatry (2008) 1.05
Schizophrenia--a high-risk factor for suicide: clues to risk reduction. Suicide Life Threat Behav (1992) 1.02
Antisuicide properties of psychotropic drugs: a critical review. Harv Rev Psychiatry (2004) 1.00
Risk factors for suicide in patients with schizophrenia: nested case-control study. Br J Psychiatry (1997) 1.00
Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizophr Res (2003) 1.00
Depression, hopelessness and suicide in chronic schizophrenia. Br J Psychiatry (1986) 0.99
Lithium for schizophrenia. Cochrane Database Syst Rev (2007) 0.98
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences. Acta Psychiatr Scand (1983) 0.98
Suicide among schizophrenics: a review. Compr Psychiatry (1985) 0.98
Gender differences in schizophrenia. J Nerv Ment Dis (1995) 0.97
Depression, attempted suicide, and suicide in patients with chronic schizophrenia. Psychiatr Clin North Am (1986) 0.96
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol Psychiatry (2003) 0.96
Co-occurring depressive symptoms in the older patient with schizophrenia. Drugs Aging (2008) 0.96
Suicide rates among public mental health patients. Acta Psychiatr Scand (1982) 0.95
The Iowa 500: suicide in mania , depression, and schizophrenia. Am J Psychiatry (1975) 0.95
Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial. Suicide Life Threat Behav (2007) 0.93
Depression in schizophrenia: recognition and management in the USA. Schizophr Res (2001) 0.92
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. J Clin Psychopharmacol (1998) 0.92
Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry (1990) 0.92
Suicide in psychiatric in-patients. Br J Psychiatry (1982) 0.91
The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. J Neuropsychiatry Clin Neurosci (2001) 0.91
Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophr Res (2006) 0.91
Mortality in schizophrenia. A ten-year follow-up based on the Stockholm County inpatient register. Arch Gen Psychiatry (1986) 0.90
Life satisfaction and suicidal attempts among persons with schizophrenia. Compr Psychiatry (2003) 0.89
Psychodynamic treatment of schizophrenia: is there a future? Psychol Med (1990) 0.88
Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res (2001) 0.88
Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatr Serv (1998) 0.87
Reducing the risk for suicide in schizophrenia and affective disorders. J Clin Psychiatry (2003) 0.87
Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J Clin Psychopharmacol (2002) 0.86
Integrated treatment of schizophrenia. Psychiatr Serv (2003) 0.85
Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial. J Clin Psychiatry (1999) 0.85
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients. Int Clin Psychopharmacol (1994) 0.85
Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin Neuropharmacol (1998) 0.84
Managing suicidality in schizophrenia. Can J Psychiatry (2007) 0.84
Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study. Biol Psychiatry (1992) 0.83
Factors predicting suicide in psychotic patients. Eur Arch Psychiatry Clin Neurosci (1992) 0.83
Suicide in schizophrenia: the Iowa Record Linkage Study. J Clin Psychiatry (1985) 0.83
Circumstances of suicide among individuals with schizophrenia. Schizophr Res (2002) 0.83
Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial. J Clin Psychiatry (2010) 0.83
Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand (1995) 0.83
The special characteristics of suicide in hospital in-patients. Br J Psychiatry (1984) 0.82
Suicide victims with schizophrenia in different treatment phases and adequacy of antipsychotic medication. J Clin Psychiatry (1999) 0.82
Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study. Acta Psychiatr Scand (1996) 0.82
Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine. J Clin Psychiatry (2005) 0.82
Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial. Arch Gen Psychiatry (1987) 0.82
Management of schizophrenia with suicide risk. Psychiatr Clin North Am (2009) 0.82
Fluoxetine augmentation of clozapine treatment in patients with schizophrenia. Am J Psychiatry (1996) 0.81
Patterns of self-destructive behaviour in schizophrenia. Acta Psychiatr Scand (1986) 0.81
Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period. Psychopharmacology (Berl) (2004) 0.81
Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database. Am J Psychiatry (2001) 0.81
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry (2008) 4.98
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Am J Psychiatry (2012) 3.73
Does bereavement-related major depression differ from major depression associated with other stressful life events? Am J Psychiatry (2008) 3.07
Complicated grief and related bereavement issues for DSM-5. Depress Anxiety (2011) 2.77
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry (2007) 1.67
The current state of genetics training in psychiatric residency: views of 235 U.S. educators and trainees. Acad Psychiatry (2010) 1.56
The Bereavement Exclusion for the Diagnosis of Major Depression: To be, or not to be. Psychiatry (Edgmont) (2010) 1.51
Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults. Am J Psychiatry (2013) 1.50
Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res (2009) 1.40
Subthreshold depression and successful aging in older women. Am J Geriatr Psychiatry (2010) 1.29
Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry (2007) 1.25
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res (2009) 1.18
In response to "Details on suicide among US physicians: data from the National Violent Death Reporting System". Gen Hosp Psychiatry (2013) 1.12
Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry (2011) 1.12
Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann Clin Psychiatry (2006) 1.06
Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disord (2006) 1.05
Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depression. J Nerv Ment Dis (2008) 1.04
The suicide prevention and depression awareness program at the University of California, San Diego School of Medicine. Acad Med (2012) 1.03
Suicide bereavement and complicated grief. Dialogues Clin Neurosci (2012) 1.03
Depression in Asian-American and Caucasian undergraduate students. J Affect Disord (2010) 1.00
Gender, depressive symptoms and patterns of alcohol use among college students. Psychopathology (2010) 1.00
Efficacy of noradrenergic and serotonergic antidepressants in chronic back pain: a preliminary concentration-controlled trial. J Clin Psychopharmacol (2007) 0.99
Do atypical features affect outcome in depressed outpatients treated with citalopram? Int J Neuropsychopharmacol (2009) 0.98
Rationale for a posttraumatic stress spectrum disorder. Psychiatr Clin North Am (2002) 0.98
Co-occurring depressive symptoms in the older patient with schizophrenia. Drugs Aging (2008) 0.96
Depression and grief reactions in hospice caregivers: from pre-death to 1 year afterwards. J Affect Disord (2002) 0.95
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. Depress Anxiety (2009) 0.95
Anxious depression: clinical features and treatment. Curr Psychiatry Rep (2009) 0.95
Depression and suicidal ideation in college students. Psychopathology (2012) 0.94
Insight in schizophrenia: a review of etiological models and supporting research. Compr Psychiatry (2007) 0.94
A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain (2016) 0.90
Psychiatric residents' views of quality of psychotherapy training and psychotherapy competencies: a multisite survey. Acad Psychiatry (2010) 0.89
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial. Eur Neuropsychopharmacol (2011) 0.88
Adaptation to bereavement. Death Stud (2005) 0.88
The prevalence of compulsive eating and exercise among college students: an exploratory study. Psychiatry Res (2008) 0.88
The relationship of marital status and clinical characteristics in middle-aged and older patients with schizophrenia and depressive symptoms. Ann Clin Psychiatry (2010) 0.88
Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial. Psychiatr Serv (2011) 0.88
Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D. Psychiatr Serv (2008) 0.87
Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. J Clin Psychopharmacol (2010) 0.85
Functioning in middle aged and older patients with schizophrenia and depressive symptoms: relationship to psychopathology. Am J Geriatr Psychiatry (2008) 0.84
Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report. Am J Geriatr Psychiatry (2008) 0.84
Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care. J Psychiatr Pract (2014) 0.84
Compulsive alcohol use and other high-risk behaviors among college students. Am J Addict (2010) 0.83
Does pretreatment insomnia or anxiety predict acute response to bupropion SR? Ann Clin Psychiatry (2005) 0.83
Burnout in premedical undergraduate students. Acad Psychiatry (2012) 0.83
Late-life depression. How to identify its symptoms and provide effective treatment. Geriatrics (2002) 0.82
Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study. Int J Geriatr Psychiatry (2010) 0.82
Helping psychiatry residents cope with patient suicide. Acad Psychiatry (2014) 0.80
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial. Depress Anxiety (2012) 0.79
Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry (2013) 0.79
"Collateral damages": preparing residents for coping with patient suicide. Acad Psychiatry (2013) 0.79
When is grief a disease? Lancet (2012) 0.78
Gender, AIDS, and bereavement: a comparison of women and men living with HIV. Death Stud (2004) 0.78
Suicidal behavior in the older patient with schizophrenia. Aging health (2011) 0.78
Elderly patients with schizophrenia and depression: diagnosis and treatment. Clin Schizophr Relat Psychoses (2011) 0.77
Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response. Am J Geriatr Psychiatry (2010) 0.77
Depression in premedical undergraduates:a cross-sectional survey. Prim Care Companion J Clin Psychiatry (2010) 0.77
Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression? Neuropsychobiology (2012) 0.77
Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning. Int J Geriatr Psychiatry (2010) 0.77
Insight, quality of life, and functional capacity in middle-aged and older adults with schizophrenia. Int J Geriatr Psychiatry (2008) 0.77
Do psychiatry residents identify as psychotherapists? A multisite survey. Ann Clin Psychiatry (2011) 0.77
Psychiatry resident/fellow-initiated and -designed multi-modal psychopharmacology curriculum for major depression. Acad Psychiatry (2012) 0.77
Improving the pedagogy associated with the teaching of psychopharmacology. Acad Psychiatry (2007) 0.76
Teaching the teacher: a report from the third annual American Society of Clinical Psychopharmacology teaching session. J Clin Psychiatry (2013) 0.76
The removal of the bereavement exclusion in the DSM-5: exploring the evidence. Curr Psychiatry Rep (2013) 0.76
Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms. Indian J Psychiatry (2013) 0.76
The challenge of teaching psychopharmacology in the new millennium: the role of curricula. Acad Psychiatry (2005) 0.76
Grief in health care professionals: when screening for major depression is needed. Arch Intern Med (2012) 0.75
Erratum to Burnout in Premedical Undergraduate Students. Acad Psychiatry (2012) 0.75
Assessing the need for a multi-modal curriculum in psychopharmacology education. Acad Psychiatry (2012) 0.75
Why I like being an academic psychiatrist. Acad Psychiatry (2012) 0.75
A tale of two veterans: homeless vs domiciled veterans presenting to a psychiatric urgent care clinic. Ann Clin Psychiatry (2013) 0.75
Narrative evolution and assimilation of problematic experiences in a case of pharmacotherapy for schizophrenia. Psychother Res (2011) 0.75
The challenge of teaching psychopharmacology and improving clinical practice. J Clin Psychopharmacol (2005) 0.75
Is there a therapeutic window with some antidepressants for analgesic response? Curr Pain Headache Rep (2009) 0.75
Alcohol use in an academic medical school environment: A UC San Diego Healer Education Assessment and Referral (HEAR) Report. Ann Clin Psychiatry (2016) 0.75